Tobira Therapeutics Reports Second Quarter 2016 Financial and Business Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Tobira Therapeutics (TBRA) Posts Q2 Loss of $0.71/Share; Ended Qtr with $41M in Cash
August 9, 2016 4:59 PM EDTTobira Therapeutics (NASDAQ: TBRA) reported Q2 EPS of ($0.71), $0.08 worse than the analyst estimate of ($0.63). Revenue for the quarter came in at $1.06 million versus the consensus estimate of $50 thousand.
s of June 30, 2016, Tobira had cash, cash equivalents, and restricted cash of $41.0... More
